Best Life Sciences Companies in United States

#1

Verily Unicorn Series D

location_onDallas, Texas

A data platform and technology company purpose-built to power AI-enabled precision health. The company combine deep clinical, regulatory, and technological expertise to provide customers with patient-centric solutions that make healthcare more personal and precise. The solutions are designed to make healthcare data AI-ready and fit for purpose across care, research, and public health.

#2

Neuralink Unicorn Series E

location_onFremont, California

Provider of implantable brain-computer interfaces. It offers flagship product the N1 Implant the Link which is a coin-sized device designed to decode neural signals and enable users to control digital devices using only their thoughts. It also has an experimental device called Blindsight to restore vision in individuals with optic nerve damage by directly stimulating the visual cortex.

#3

Quince Therapeutics Public

location_onSan Francisco, California

Developer of therapeutics for orthopedic diseases. It offers a lead candidate NOV004 which is an anabolic peptide engineered to target and concentrate at the bone fracture site and also helps in spinal fusion and osteogenesis Imperfecta.

#4

Earendil Series D

location_onMiddletown, Delaware

Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics. It transform the discovery of protein therapeutics using deep learning and high-throughput biology. The company aims to deliver transformative medicines to patients worldwide through its innovative approaches.

#5

Imperative Care Series E

location_onCampbell, California

Provider of access catheters for cardiovascular diagnosis and treatment. The catheters are used in deep navigation into the blood vessels of the brain to prevent strokes. The flagship product ZOOM Aspiration System is a family of products designed to facilitate clot removal during ischemic stroke.

#6

GRAIL Public

location_onMenlo Park, California

Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.

#7

Achieve Life Sciences Public

location_onSeattle, Washington

Developer of plant-based alkaloid for treating smoking cessation. The company is developing Cytisinicline, which is a plant-based alkaloid with a binding affinity to the α4β2 nicotine receptor. The candidate is expected to block nicotine cravings and reduce the severity of nicotine withdrawal symptoms.

#8

Immunic Public

location_onNew York City, New York

Developer of oral immunology therapies for treating chronic inflammatory and autoimmune diseases. The product pipeline of the company includes vidofludimus calcium (IMU-838), a selective immune modulator for multiple sclerosis, IMU-935, a selective inverse agonist targeted for psoriasis, castration-resistant prostate cancer, and Guillain-Barré syndrome and IMU-856, for bowel barrier dysfunction.

#9

Senti Bio Public

location_onSan Francisco, California

Developer of cell and gene therapies for patients living with incurable diseases. The company has developed its proprietary synthetic biology platform to produce cell and gene therapies for cancer treatment. The company's pipeline is comprised of cell therapies engineered with Gene Circuits to target difficult to treat liquid and solid tumors. It offers CAR-NK-based therapies for multiple cancer and tumors.

#10

Apnimed Series C

location_onCambridge, Massachusetts

Developer of small molecule-based therapeutics for the treatment of obstructive sleep apnea. The company has developed a combination of Atomoxetine and Oxybutynin which reduces the obstructive sleep apnea severity. It targets the neurological control and activation of upper airway dilator muscles which improve respiration and oxygenation during sleep.

#11

Bioventrix Series E

location_onSan Ramon, California

BioVentrix develops clinical solutions for treating heart failure patients. It provides PliCath HF, an epicardial catheter-based ventricular reconstruction device. Product is not commercially available.

#12

Terremoto Series C

location_onSan Francisco, California

Developer of small-molecule therapeutics for cancer treatment. It provides a lysine-targeted covalency platform to develop therapies against known drug targets for oncology.